These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20620234)

  • 1. An alternative technique of implanting a nontransvenous implantable cardioverter-defibrillator system in adults with no or limited venous access to the heart.
    Kowalski M; Nicolato P; Kalahasty G; Kasirajan V; Wood MA; Ellenbogen KA; Shepard RK
    Heart Rhythm; 2010 Nov; 7(11):1572-7. PubMed ID: 20620234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach.
    Schneider AE; Burkhart HM; Ackerman MJ; Dearani JA; Wackel P; Cannon BC
    Heart Rhythm; 2016 Sep; 13(9):1905-12. PubMed ID: 27321244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
    Rydlewska A; Machejek J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy.
    Almquist AK; Montgomery JV; Haas TS; Maron BJ
    Heart Rhythm; 2005 Aug; 2(8):814-9. PubMed ID: 16051115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
    Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of basic electrical features of ICD defibrillating leads implanted to right ventricular apex or right ventricular outflow track and septum].
    Szafraniec Z; Kaczmarek K; Pałka K; Ptaszyński P; Ruta J; Chudzik M; Wranicz JK
    Pol Merkur Lekarski; 2014 Mar; 36(213):155-9. PubMed ID: 24779211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
    Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years.
    Tomaske M; Prêtre R; Rahn M; Bauersfeld U
    Europace; 2008 Oct; 10(10):1152-6. PubMed ID: 18701602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontraditional implantable cardioverter defibrillator placement in adult patients with limited venous access: a case series.
    Bhakta M; Obioha CC; Sorajja D; Srivathsan K; Arabia FA; Devaleria PA; Jaroszewski DE; Scott LR; Altemose GT
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):217-25. PubMed ID: 19804488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous implantable cardioverter-defibrillator: Initial experience.
    Galvão P; Cavaco D; Adragão P; Costa F; Carmo P; Morgado F; Bernardo R; Nunes M; Abecasis M; Neves J; Mendes M
    Rev Port Cardiol; 2014 Sep; 33(9):511-7. PubMed ID: 25242675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completely epicardial implantable cardioverter/defibrillator (ICD) and CRT-D systems: A case series and systematic literature review.
    Tonko JB; Blauth C; Rosenthal E; Rinaldi CA
    Pacing Clin Electrophysiol; 2021 Sep; 44(9):1616-1630. PubMed ID: 34287989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart.
    Cannon BC; Friedman RA; Fenrich AL; Fraser CD; McKenzie ED; Kertesz NJ
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):181-7. PubMed ID: 16492305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections.
    Dhamija RK; Tan H; Philbin E; Mathew RO; Sidhu MS; Wang J; Saour B; Haqqie SS; Beathard G; Yevzlin AS; Salman L; Boden WE; Siskin G; Asif A
    Am J Kidney Dis; 2015 Jul; 66(1):154-8. PubMed ID: 25911316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.